Insulin aspart, recombinant Subcutaneous and Koate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Koate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Koate-DVI
- Insulin aspart, recombinant Subcutaneous-Koate-DVI human
- Insulin aspart, recombinant Subcutaneous-Kogenate FS
- Insulin aspart, recombinant Subcutaneous-Kogenate FS Bio-Set
- Insulin aspart, recombinant Subcutaneous-Kogenate FS recombinant
- Insulin aspart, recombinant Subcutaneous-Kola-Pectin
- Koate-Insulin degludec
- Koate-Insulin Degludec (U-100) Prefilled Pens
- Koate-Insulin Degludec (U-100) Vials
- Koate-Insulin Degludec (U-200) Prefilled Pens
- Koate-Insulin degludec and liraglutide
- Koate-Insulin degludec and liraglutide Subcutaneous